JP2009538614A - プロバイオティクス菌株及びこれに由来する抗菌性ペプチド - Google Patents

プロバイオティクス菌株及びこれに由来する抗菌性ペプチド Download PDF

Info

Publication number
JP2009538614A
JP2009538614A JP2009512739A JP2009512739A JP2009538614A JP 2009538614 A JP2009538614 A JP 2009538614A JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009538614 A JP2009538614 A JP 2009538614A
Authority
JP
Japan
Prior art keywords
peptide
st4sa
strain
concentration
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538614A5 (https=
Inventor
レオン ミルネア セオドア ディックス，
スヴェトスラフ ディミトロフ トドロフ，
ヘンドリエッテ ノエッツェ，
マレライズ ブリンク，
Original Assignee
シプラ メドプロ リサーチ アンド デヴェロップメント （プロプライエタリー） リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx
Application filed by シプラ メドプロ リサーチ アンド デヴェロップメント （プロプライエタリー） リミテッド filed Critical シプラ メドプロ リサーチ アンド デヴェロップメント （プロプライエタリー） リミテッド
Publication of JP2009538614A publication Critical patent/JP2009538614A/ja
Publication of JP2009538614A5 publication Critical patent/JP2009538614A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009512739A 2006-05-28 2007-05-25 プロバイオティクス菌株及びこれに由来する抗菌性ペプチド Pending JP2009538614A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200604035A ZA200604035B (en) 2005-05-31 2006-05-28 Improved grenade launcher
PCT/IB2007/051982 WO2007138538A2 (en) 2006-05-28 2007-05-25 Probiotic strain and antimicrobial peptide derived therefrom

Publications (2)

Publication Number Publication Date
JP2009538614A true JP2009538614A (ja) 2009-11-12
JP2009538614A5 JP2009538614A5 (https=) 2010-06-24

Family

ID=38779065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512739A Pending JP2009538614A (ja) 2006-05-28 2007-05-25 プロバイオティクス菌株及びこれに由来する抗菌性ペプチド

Country Status (13)

Country Link
US (2) US7951385B2 (https=)
EP (1) EP2021457B1 (https=)
JP (1) JP2009538614A (https=)
KR (1) KR101521123B1 (https=)
CN (1) CN101454440B (https=)
AP (1) AP2841A (https=)
AU (1) AU2007266675B2 (https=)
CA (1) CA2647161A1 (https=)
EA (1) EA017558B1 (https=)
IL (2) IL195520A0 (https=)
NO (1) NO20084577L (https=)
NZ (1) NZ571619A (https=)
WO (1) WO2007138538A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
JP2018537126A (ja) * 2015-11-17 2018-12-20 プレミア リサーチ ラボズ, リミテッドパートナーPremier Research Labs, LP ジヒドロリポ酸の生成・抽出プロセス
WO2019151371A1 (ja) * 2018-01-31 2019-08-08 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드
US8357519B2 (en) * 2008-11-19 2013-01-22 The Ohio State University Methods and processes for producing esters
WO2011045764A1 (en) * 2009-10-15 2011-04-21 Cipla Medpro Research And Development (Pty) Ltd A product for delivering antimicrobially active substances to an infected site
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
RU2532227C1 (ru) * 2013-10-23 2014-10-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) * 2015-07-23 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
CN105385636A (zh) * 2015-12-07 2016-03-09 江南大学 一株产细菌素的肠膜明串珠菌及其应用
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
AU2018336988B2 (en) * 2017-09-19 2023-06-22 Advaxis, Inc. Compositions and methods for lyophilization of bacteria or Listeria strains
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
CN109456911B (zh) * 2018-10-10 2019-10-18 南京林业大学 一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) * 2019-12-18 2021-03-02 江南大学 一株降低生物胺的肉葡萄球菌及其应用
KR102951826B1 (ko) * 2023-01-18 2026-04-13 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238465A (ja) * 2001-02-05 2002-08-27 Nutrinova Nutrition Specialties & Food Ingredients Gmbh 農業家畜飼育用飼料への添加物としてのプロバイオテックス含有ソルビン酸調製物
JP2003339377A (ja) * 2002-05-23 2003-12-02 Prima Meat Packers Ltd 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1084969A (ja) 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) * 1997-09-05 2010-02-02 Canbiocin, Inc. Expression vectors for treating bacterial infections
AU7898700A (en) 1999-10-22 2001-05-08 Shanghai Bio Road Gene Development Ltd. A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
GB0125535D0 (en) 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US6878373B2 (en) 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238465A (ja) * 2001-02-05 2002-08-27 Nutrinova Nutrition Specialties & Food Ingredients Gmbh 農業家畜飼育用飼料への添加物としてのプロバイオテックス含有ソルビン酸調製物
JP2003339377A (ja) * 2002-05-23 2003-12-02 Prima Meat Packers Ltd 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
JPN6012026131; Ａｐｐｌ　Ｅｎｖｉｒｏｎ　Ｍｉｃｒｏｂｉｏｌ．，　２００２年，　第６８巻，　３８３０-３８４０ページ *
JPN6012026132; Ａｎｔｉｍｉｃｒｏｂ　Ａｇｅｎｔｓ　Ｃｈｅｍｏｔｈｅｒ．，　２００４年，　第４８巻，　２７７８-２７８１ページ *
JPN6012026135; Ｉｎｔ　Ｊ　Ａｎｔｉｍｉｃｒｏｂ　Ａｇｅｎｔｓ．，　１９９９年，　第１２巻，　２９３-２９９ページ *
JPN6013036188; Ｆｅｅｄ　Ｍｉｘ　Ｓｐｅｃｉａｌ，　２０００年，　２８-３０ページ *
JPN6013036189; Ｉｎｔ　Ｊ　Ｆｏｏｄ　Ｍｉｃｒｏｂｉｏｌ．，　１９９９年，　第４７巻，　１-２４ページ *
JPN6013036190; Ａｎａｅｒｏｂｅ，　１９９７年，　第３巻，　７３-７８ページ *
JPN6013036191; Ｉｎｔ　Ｊ　Ｆｏｏｄ　Ｍｉｃｒｏｂｉｏｌ．，　２００６年１月，　第１０６巻，　１-２４ページ *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
JP2018537126A (ja) * 2015-11-17 2018-12-20 プレミア リサーチ ラボズ, リミテッドパートナーPremier Research Labs, LP ジヒドロリポ酸の生成・抽出プロセス
WO2019151371A1 (ja) * 2018-01-31 2019-08-08 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤
JPWO2019151371A1 (ja) * 2018-01-31 2021-01-07 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤
JP7289798B2 (ja) 2018-01-31 2023-06-12 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤
US11911420B2 (en) 2018-01-31 2024-02-27 Nutri Co., Ltd. Prophylactic and/or therapeutic agents for Streptococcus pneumoniae infection

Also Published As

Publication number Publication date
AU2007266675A1 (en) 2007-12-06
AU2007266675B2 (en) 2012-09-06
US20110268703A1 (en) 2011-11-03
AP2841A (en) 2014-02-28
AP2008004626A0 (en) 2008-10-31
US20090297482A1 (en) 2009-12-03
CA2647161A1 (en) 2007-12-06
US8444998B2 (en) 2013-05-21
NO20084577L (no) 2008-12-19
KR101521123B1 (ko) 2015-05-19
EP2021457B1 (en) 2015-02-11
NZ571619A (en) 2011-10-28
IL195520A0 (en) 2011-08-01
WO2007138538A3 (en) 2008-04-17
IL250634A0 (en) 2017-03-30
EA017558B1 (ru) 2013-01-30
KR20090023626A (ko) 2009-03-05
EA200802409A1 (ru) 2009-10-30
CN101454440A (zh) 2009-06-10
US7951385B2 (en) 2011-05-31
WO2007138538A2 (en) 2007-12-06
EP2021457A2 (en) 2009-02-11
CN101454440B (zh) 2013-05-29

Similar Documents

Publication Publication Date Title
US8444998B2 (en) Probiotic strain and antimicrobial peptide derived therefrom
EP0760848B1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
Zamani et al. Antibiofilm potential of Lactobacillus plantarum spp. cell free supernatant (CFS) against multidrug resistant bacterial pathogens
Jeronymo-Ceneviva et al. Probiotic properties of lactic acid bacteria isolated from water-buffalo mozzarella cheese
CA2280704A1 (en) Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
CA3027458A1 (en) Dermatological preparations for maintaining and/or restoring healthy skin microbiota
CN113430174A (zh) 一株高裂解性沙门氏菌噬菌体rdp-sa-19009及其应用
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
US9963488B2 (en) Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
US6040421A (en) Escherichia coli O157:H7 epithelial adhesion and vaccine
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof
CN114574405B (zh) 植物乳杆菌菌株wka86及其在制备防治口臭制品方面的用途与制品
TW201200162A (en) Lactobacillus salivarius for improving oral bacterial groups and health care compositions thereof
JP2004519236A (ja) ビフィドバクテリウム由来の新規なプラスミド、これを利用した組換え発現ベクターおよび形質転換方法
KR100646938B1 (ko) 헬리코박터 필로리의 정착과 생육 활성을 저해하는락토바실루스 람노서스 아이디씨씨 3201
Movsesyan et al. Properties and survival under simulated gastrointestinal conditions of lactic acid bacteria isolated from Armenian cheeses and matsuns
CN114149942A (zh) 一株东洋芽孢杆菌及其应用
Aman et al. Mitigating Virulence of Environmental Enterococcus faecalis Via Fermented Food-Derived Lactic Acid Bacteria
Kumada et al. Effects of Enterococcus faecium on Streptococcus mutans biofilm formation using flow cell system
KR102003786B1 (ko) 신규한 시가톡신 생성 대장균 특이 박테리오파지 ecoh7 및 이를 포함하는 항균 조성물
WO2023150886A1 (en) Probiotic strain for countering caries pathogens
WO2026030202A1 (en) Curating a biofilm using bioengineered bacteria
Liew Anchors away: Determining the role of outer membrane proteins in Pseudomonas aeruginosa vesicle formation
Teixeira FSR Quorum Sensing: Role in Enterococcus faecalis Biology & Host Infection
PANWAR Production and purification of native and recombinant surface layer protein (S-layer protein) from probiotic Lactobacillus spp.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100430

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100430

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120821

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120828

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130723

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131018

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131025

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140422